Studies have shown that targeting the NLRP3 inflammasome signaling pathway in microglia effectively attenuates cognitive deficits in PND and is a potential target for the prevention and treatment of neuroinflammatory diseases [89, 90]. The gene discussed is NLRP3; the disease is Cognitive impairment.